V
Velocity Clinical Research | Norfolk, NE
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
RTA 901
BIIB143
Parent organization
This site is a part of Velocity Clinical Research
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 10 total trials
The purpose of this study is to evaluate the safety and reactogenicity of mRNA-1195 in healthy participants.
Active, not recruiting
Epstein-Barr Virus Infection
Biological: Placebo
Biological: mRNA-1195.1
This is a Phase 4, post-market US study, evaluating the efficacy and safety of a single dose of the NVX-CoV2705 Omicron JN.1 COVID-19 vaccine. Approx...
Active, not recruiting
COVID-19
Sars-CoV-2 Infection
Biological: NVX-CoV2705
Biological: Placebo
The purpose of the Part A Phase 1 of this study is to evaluate the safety, reactogenicity, and immunogenicity of mRNA-1403 and mRNA-1405 in healthy a...
Active, not recruiting
Norovirus Acute Gastroenteritis
Biological: mRNA-1405
Biological: mRNA-1403
Trial sponsors
Clinical trials
Research sites
Resources
Legal
© Copyright 2026 Veeva Systems